Enhanced Group Inc. Form 8-K Filing

Enhanced Group Inc. has entered into a Securities Purchase Agreement for a private placement expected to raise approximately $50.0 million. The agreement involves the issuance of Class A common stock and accompanying warrants. Key investors include Apeiron Investment Group Limited and CEO Maximilian Martin. The proceeds will be used for working capital, general corporate purposes, and to accelerate the growth of their telehealth and consumer health platform, as well as to repay an outstanding promissory note to Apeiron. The private placement is structured in tranches, with the first closing expected around June 17, 2026. The warrants are exercisable for five years, with provisions for accelerated expiration under certain conditions and anti-dilution adjustments. The company has also entered into a Registration Rights Agreement to facilitate the resale of the issued shares and underlying warrant shares. The filing also details the termination of a material definitive agreement related to the promissory note upon repayment.